NAFLD is Common in Patients With T2DM and Associated With Severe Insulin Resistance (IR) and Risk Factors for Cardiovascular Disease (CVD)

被引：0
|
作者：
Lomonaco, Romina
Ortiz-Lopez, Carolina
Orsak, Beverly
Finch, Joan
Kaminski-Graham, Rose
Cusi, Kenneth
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1780-P
引用
收藏
页码：A458 / A458
页数：1
相关论文
共 50 条
  • [21] Dietary factors in the risk of T2DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 537 - 537
  • [22] Insulin Resistance: A Bridge between T2DM and Alzheimer's Disease
    Giacomazza, Daniela
    Di Carlo, Marta
    JOURNAL OF DIABETES & METABOLISM, 2013, 4 (04)
  • [23] Dietary factors in the risk of T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2020, 16 : 537 - 537
  • [24] Liver Fibrosis Is Common in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD)
    Lomonaco, Romina
    Fanous, Nada
    Kalavalapalli, Srilaxmi
    Tejera, Lazaro J.
    McCauley, Allison
    Godinez, Eddison
    Mansour, Lydia
    Shrestha, Sulav
    Marte, Jonathan S.
    Fakhry, Jonathan
    Wang, Hannah
    Barb, Diana
    Bril, Fernando
    Cusi, Kenneth
    DIABETES, 2020, 69
  • [25] Is NAFLD an independent risk factor for increased IMT in T2DM?
    Cakir, E.
    Ozbek, M.
    Colak, N.
    Cakal, E.
    Delibasi, T.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (02) : 187 - 193
  • [26] Acanthosis nigricans suggesting insulin resistance and secretion in T2DM patients
    Sharma, L.
    Mathur, S. K.
    Khilnani, G.
    Mathur, M.
    Mathur, P.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 226 - 226
  • [27] Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?
    Alemany-Pages, Mireia
    Moura-Ramos, Mariana
    Araujo, Sara
    Macedo, Maria Paula
    Ribeiro, Rogerio T.
    do O, Dulce
    Ramalho-Santos, Joao
    Azul, Anabela Marisa
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [28] Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?
    Mireia Alemany-Pagès
    Mariana Moura-Ramos
    Sara Araújo
    Maria Paula Macedo
    Rogério T. Ribeiro
    Dulce do Ó
    João Ramalho-Santos
    Anabela Marisa Azul
    BMC Public Health, 20
  • [29] Unravelling the enigma of T2DM and cardiovascular disease
    Donald W. Bowden
    Amanda J. Cox
    Nature Reviews Endocrinology, 2013, 9 : 632 - 633
  • [30] Efficacy and Tolerability of Saxagliptin (SAXA) in Patients With Type 2 Diabetes Mellitus (T2DM) and a History of Cardiovascular Disease (CVD)
    Minervini, Gianmaria
    Cook, William
    Allen, Elsie
    DIABETES, 2013, 62 : A306 - A306
12345